Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson's ortho-clinical testing business for $4.15 billion, according to a Mass Device report.
The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.
More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement
More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement